Schedule 13D ownership disclosure
Apogee Therapeutics Inc
Security class unavailable · CUSIP: 03770N101
Event date: 2023-07-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,887,478
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-085333
- Form type
- SC 13D
- Filer
- Apogee Therapeutics, Inc.
- CIK
- CIK 1974640
- Filed
- Jul 28, 2023
- Reporting period
- Jul 18, 2023
- Description
- Schedule 13D beneficial ownership